<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
-------------
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of the
Securities and Exchange Act of 1934
January 5, 1996
- --------------------------------------------------------------------------------
Date of Report (Date of earliest event reported)
Response Oncology, Inc.
- --------------------------------------------------------------------------------
(Exact name of registrant as specified in charter)
Tennessee 0-15416 62-1212264
- --------------------------------------------------------------------------------
(State or other (Commission (IRS Employer
jurisdiction of File Number) Identification No.)
incorporation)
1775 Moriah Woods Blvd.
Memphis, Tennessee 38117
- --------------------------------------------------------------------------------
(Address of principal executive offices)
(901) 761-7000
- --------------------------------------------------------------------------------
(Registrant's telephone number, including area code)
Response Technologies, Inc.
- --------------------------------------------------------------------------------
(Former name or former address, if changed since last report)
<PAGE> 2
ITEM 5: OTHER EVENTS
Reference press release attached as Exhibit 99.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended, the Registrant has duly caused this report to be filed on its behalf
by the undersigned thereunto duly authorized.
Dated: January 5, 1996
Response Oncology, Inc.
By: /s/ Daryl P. Johnson
--------------------
Daryl P. Johnson
Vice President and
Chief Financial Officer
<PAGE> 1
EXHIBIT 99
RESPONSE ONCOLOGY, INC. ANNOUNCES
APPOINTMENT OF NEW DIRECTOR
MEMPHIS, TENNESSEE (January 3, 1996) -- Response Oncology, Inc. today
announced the appointment of Leonard A. Kalman, M.D. to its Board of Directors.
Dr. Kalman, a co-medical director of the Baptist Hospital of Miami Regional
Cancer Center, is a practicing oncologist with the Oncology Hematology Group of
South Florida, P.A. (the "Group"). Dr. Kalman is a graduate of Wesleyan
University, and the Duke University School of Medicine. Among his other
appointments, Dr. Kalman was a fellow in medical oncology at the Memorial Sloan
Kettering Cancer Center in New York. He has been in private practice in Miami,
Florida since 1982.
In a separate statement, the Company announced that it has acquired the assets
of, and entered into a long-term management services agreement with the Group.
The Group is the Company's first physician group under such a practice
management relationship. The Company has plans to establish additional
relationships of this nature in the future.
The Company also announced that it has named Joseph T. Clark as Chief Executive
Officer of the Company in addition to his duties as President. This will allow
the Company's Chairman, William H. West, M.D., to concentrate on medical and
scientific affairs of the Company, particularly in connection with refining
disease management capabilities to support managed care marketing. Mr. Clark
has served as President of the Company since 1993.
Dr. West stated "We are very pleased to add Dr. Kalman to our Board of
Directors. We believe that he will be very valuable in helping to guide the
Company's physician practice management strategy. Further, we believe that Mr.
Clark's appointment to the position of CEO is appropriate as the Company's
business plans evolve to include oncology practice management services and
cancer care networks."
Response Oncology is a comprehensive cancer management company which owns
and/or operates a network of outpatient treatment centers, or IMPACT(R)
Centers, which provide stem cell supported high dose chemotherapy and other
advanced cancer treatment services under the direction of practicing
oncologists; owns the assets of and manages oncology practices; and conducts
clinical cancer research on behalf of pharmaceutical manufacturers. Over 300
medical oncologists are affiliated with the Company.
The common stock of Response Oncology, Inc. is traded on the NASDAQ National
Market under the symbol ROIX.
* * * * *
